Written Testimony in Support of Maryland House Bill 1134 Pharmaceutical Drugs and Devices – Gifts to Health Professionals – Prohibition March 10, 2026
Testimony in Support Of Maryland Bill To Eliminate Tax Deduction For Direct-to-Consumer Drugs Ads March 9, 2026
Opinion Article in BMJ Evidence-Based Medicine: FDA Pathway for Drug Innovations Allows Approval of High-Priced, Minimally Modified Drugs Based on Limited Data March 2, 2026